| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | 0.47 | 0.02 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.02 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.02 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.094 | 0.02 |